Technology | October 17, 2007

MEDRAD Injection System Senses Media Pooling, Stops Injection

The MEDRAD Stellant CT Injection System provides saline flush capabilities and protocol options.

The DualFlow upgrade enables simultaneous injection of contrast and saline while the XDS detects the start of an extravasation by directly sensing contrast media pooling under the skin and automatically stopping injection until a clinician can examine the patient.

The Spectris Solaris EP MR Injection System, also featured at RSNA, promises enhanced power management performance through longer battery life and an Integrated Continuous Battery Charger (iCBC) option.

For current and emerging needs in the MR environment, the newest MR injector from the MEDRAD is compatible with all magnet strengths up to 3.0T, according to its manufacturer.
The MEDRAD Avanta is an advanced fluid management system that is reportedly flexible enough for multiple cardiac imaging applications.

It is intended to inject contrast in variable mode at low flow rates and low pressures for coronary and small vessels, fixed mode at high flow rates and high-pressure injections for larger vessels and peripherals and fixed mode for saline flushing.

Related Content

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
GU12171120

GU12171120

Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019
The continuing search for advantages to improve workflow has radiology departments constantly searching for new solut
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...